These surfaces provide attachment sites for microorganisms circulating in the bloodstream. Damage to the endothelium and the presence of thrombi or prosthetic material can make adherence more likely than on intact vascular surfaces. Once organisms become established, they can maintain a localized focus of infection that contributes to persistent bloodstream infection and vascular injury.
Biofilm formation creates a protected microbial community on catheters, prosthetic material, or other intravascular surfaces. This protection can limit access by immune defenses and reduce the effectiveness of antimicrobial treatment. Consequently, infection may persist despite therapy, making the involved device or material an important consideration in treatment decisions.
Inflammation at an infected vascular or cardiac site can produce infected material that enters the circulation. The overview identifies embolic complications as one possible consequence, alongside infective endocarditis, infected vascular grafts, and septic thrombosis. These outcomes reflect how a localized intravascular infection can affect distant sites as well as the original vessel or valve.
Microorganisms attached to damaged endothelium, thrombi, prosthetic material, or catheters can remain within the circulation rather than being rapidly cleared. Biofilm formation may further shield them from immune defenses and antimicrobial treatment. This protected, adherent reservoir helps explain why bloodstream infection can continue and why identifying the infected vascular or device-associated site matters.
Blood cultures help assess the bloodstream component of infection, while imaging helps evaluate affected cardiac or vascular structures. Their interpretation is supported by understanding how microorganisms adhere to endothelium, thrombi, prosthetic material, and catheters. Together, these approaches can help identify conditions such as infective endocarditis, infected vascular grafts, or septic thrombosis.
Management may require more than antimicrobial selection when infection involves an intravascular device, prosthetic material, or a structurally affected vessel or valve. The overview highlights device removal or surgery as decisions guided by diagnostic findings and the infection’s consequences. These interventions address infected material or damaged structures that may support persistence despite treatment.